Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

YM merges with Cytopia in $Cdn12mm deal

Executive Summary

YM Biosciences (therapeutics for cancer and pain) has agreed to merge with Australia's Cytopia (oncology focused, with other treatments for cardiovascular, autoimmune, and inflammatory conditions). YM will issue one of its common shares for every 11.737 Cytopia shares, or an aggregate of 7.2mm shares valued at $Cdn12mm ($11.1mm). The per share ratio of $Cdn0.17 represents a 55% premium.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Includes Contract
    • Full Acquisition
    • Intra-Biotech Deal

Related Companies